EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting

Young-Hak Kim1, Jung-Min Ahn, Duk-Woo Park

  • 1Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Insights

High surgical risk, indicated by the EuroSCORE, and the number of stents used are key predictors of adverse outcomes following unprotected left main coronary artery stenting. Glycoprotein IIb/IIIa inhibitor use also significantly increases risk.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Outcomes Research

Background:

  • Unprotected left main coronary artery stenting is a complex procedure with significant risks.
  • Identifying predictors of adverse events is crucial for patient selection and risk management.

Purpose of the Study:

  • To identify independent predictors of death and myocardial infarction (MI) after unprotected left main coronary artery stenting.
  • To evaluate the utility of systemic surgical risk stratification scores in predicting outcomes.

Main Methods:

  • Retrospective analysis of patients undergoing unprotected left main coronary artery stenting between January 2000 and March 2005.
  • Inclusion of bare metal and sirolimus-eluting stents.
  • Multivariate Cox regression analysis to determine independent predictors of death/MI, including EuroSCORE and Parsonnet score.

Main Results:

  • The study included 324 patients (148 bare metal, 176 sirolimus-eluting stents).
  • Death or MI occurred in 13% of patients during a median follow-up of 26.3 months.
  • Independent predictors of death/MI included a high EuroSCORE (≥6), increased number of stents used, and treatment with glycoprotein IIb/IIIa inhibitors.

Conclusions:

  • High surgical risk, as estimated by the EuroSCORE, is associated with unfavorable outcomes in unprotected left main coronary artery stenting.
  • The number of stents and use of glycoprotein IIb/IIIa inhibitors are significant procedural factors influencing outcomes.
  • Systemic risk stratification tools like the EuroSCORE can aid in predicting adverse events in this patient population.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...